News Nature Biotechnology 24 , 729 (2006)
Published online: 6 July 2006; | doi:10.1038/nbt0706-729
Pipeline cherrypicking deal yields lucrative return John Ransom
Lone Tree, Colorado
Exelixis is reaping the benefits of a licensing and development deal with GlaxoSmithKline that gives the pharma partner an option on 3 of 12 specified products in development.
The Seeker is looking for novel approaches to protecting maize from insect damage.
This Challenge re...
The Seeker is looking for methods to analyze consumer emotions.
This Challenge requires only a writ...
University of Texas Medical Branch
Galveston, TX United States
International Max Planck Research School for Molecular and Cellular Life Sciences
Munich 82152 Germany